Literature DB >> 2827599

Ventilatory physiology of patients with panic disorder.

J M Gorman1, M R Fyer, R Goetz, J Askanazi, M R Liebowitz, A J Fyer, J Kinney, D F Klein.   

Abstract

Thirty-one patients with DSM-III panic disorder or agoraphobia with panic attacks, 13 normal controls, and 12 patients with other anxiety disorders were studied during ventilatory challenge with room air hyperventilation and 5% carbon dioxide inhalation. Patients also underwent sodium lactate infusion. Among the patients with panic disorder, 58% panicked with sodium lactate, 39% with 5% CO2, and 23% with room air hyperventilation. Of the other patients, four panicked with sodium lactate, none with 5% CO2, and one with room air hyperventilation. One normal control panicked with both sodium lactate and 5% CO2. Panic with CO2 was associated with an exaggerated ventilatory response and increases in plasma norepinephrine level and diastolic blood pressure. Patients with panic disorder may have hypersensitive CO2 receptors that, when triggered, evoke a subjective panic associated with an exaggerated ventilatory response and consequent hypocapnic alkalosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2827599     DOI: 10.1001/archpsyc.1988.01800250035006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  38 in total

1.  Carbon dioxide hypersensitivity in separation-anxious offspring of parents with panic disorder.

Authors:  Roxann Roberson-Nay; Donald F Klein; Rachel G Klein; Salvatore Mannuzza; John L Moulton; Mary Guardino; Daniel S Pine
Journal:  Biol Psychiatry       Date:  2010-02-20       Impact factor: 13.382

Review 2.  Coping skills and exposure therapy in panic disorder and agoraphobia: latest advances and future directions.

Authors:  Alicia E Meuret; Kate B Wolitzky-Taylor; Michael P Twohig; Michelle G Craske
Journal:  Behav Ther       Date:  2011-08-27

Review 3.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

4.  Interaction between δ opioid receptors and benzodiazepines in CO₂-induced respiratory responses in mice.

Authors:  Anne H Borkowski; Dylan C Barnes; Derek R Blanchette; F Xavier Castellanos; Donald F Klein; Donald A Wilson
Journal:  Brain Res       Date:  2011-04-28       Impact factor: 3.252

5.  Evaluating the risks of clinical research: direct comparative analysis.

Authors:  Annette Rid; Emily Abdoler; Roxann Roberson-Nay; Daniel S Pine; David Wendler
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-09       Impact factor: 2.576

Review 6.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

Review 7.  Hyperventilation in panic disorder and asthma: empirical evidence and clinical strategies.

Authors:  Alicia E Meuret; Thomas Ritz
Journal:  Int J Psychophysiol       Date:  2010-05-25       Impact factor: 2.997

Review 8.  Biological characterization of social phobia.

Authors:  C M Miner; J R Davidson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

9.  Cerebral blood flow and metabolism in anxiety and anxiety disorders.

Authors:  R J Mathew
Journal:  Indian J Psychiatry       Date:  1994-07       Impact factor: 1.759

Review 10.  [Experimental provocation of panic attacks as a human experimental model for anxiety].

Authors:  A Ströhle
Journal:  Nervenarzt       Date:  2003-09       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.